Cargando…
DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information
The use of existing drugs for new therapeutic applications, commonly referred to as drug repositioning, is a way for fast and cost-efficient drug discovery. Drug repositioning in oncology is commonly initiated by in vitro experimental evidence that a drug exhibits anticancer cytotoxicity. Any indepe...
Autores principales: | Amelio, I, Gostev, M, Knight, R A, Willis, A E, Melino, G, Antonov, A V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944280/ https://www.ncbi.nlm.nih.gov/pubmed/24503543 http://dx.doi.org/10.1038/cddis.2014.9 |
Ejemplares similares
-
Large scale integration of drug-target information reveals poly-pharmacological drug action mechanisms in tumor cell line growth inhibition assays
por: Knight, Richard A., et al.
Publicado: (2014) -
SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer
por: Amelio, I, et al.
Publicado: (2016) -
Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment
por: Cousin, Margot A., et al.
Publicado: (2014) -
Review of Drug Repositioning Approaches and Resources
por: Xue, Hanqing, et al.
Publicado: (2018) -
New drugs are not enough-drug repositioning in oncology: An update
por: Armando, Romina Gabriela, et al.
Publicado: (2020)